Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
During recessions, some index funds fare better than others. This intro highlights selection criteria and defensive positioning.
25,743 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A single, high-stakes scenario could ripple through the U.S. power grid, telecom networks, and financial systems. Thi...
A private Philadelphia moment between Beyoncé and Jay-Z offers more than star power. This piece breaks down the finan...
Long-term wealth isn’t built overnight. These dividend ETF picks could deliver steady income, steady growth, and the ...
Analysts model a five-year horizon for Broadcom, showing a pathway where a $5,000 stake could grow significantly by 2...
Retirees are quietly piling into IDV, the iShares International Select Dividend ETF, chasing steady income and intern...
Markets pivot as reports say iran’s supreme leader injured; investors reassess oil supply risk, sanctions, and possib...
When the holiday season closed, Ross Stores delivered a clear message: steady demand for its off-price model and a ca...
Looking to invest with a decade-long horizon? Here are three tech stocks to buy and hold, backed by strong moats, cas...
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
A sudden government shutdown of an AI model can upend markets in days. This guide breaks down what it means for inves...
Raising Cane’s rides a World Cup wave as fans flood social feeds with praise for the chicken and sauce. The co-CEO’s ...